Key regions: United Kingdom, Germany, France, South Korea, Italy
The COVID-19 Vaccines market in Oman has been rapidly developing since the first vaccine was approved for emergency use in December 2020.
Customer preferences: Omani citizens have shown a strong willingness to receive the COVID-19 vaccine, with a high demand for the vaccine across the country. The government has been actively promoting the vaccine through various media channels and has implemented a national vaccination campaign to ensure that all citizens have access to the vaccine.
Trends in the market: The COVID-19 vaccine market in Oman has been dominated by the Pfizer-BioNTech vaccine, which was the first vaccine to be approved for emergency use in the country. However, the market has become more competitive with the approval of other vaccines such as the Oxford-AstraZeneca and Sinovac vaccines. The government has also signed agreements with other vaccine manufacturers to ensure a steady supply of vaccines for the population.
Local special circumstances: Oman has a relatively small population and a high-income economy, which has allowed the government to invest in the healthcare sector and provide free healthcare for its citizens. The government has also implemented strict measures to contain the spread of COVID-19, which has helped to control the number of cases in the country.
Underlying macroeconomic factors: The COVID-19 pandemic has had a significant impact on the global economy, and Oman has not been immune to this. The country has experienced a decline in oil prices, which has had a major impact on its economy. However, the government has implemented various measures to stimulate the economy and support businesses, which has helped to mitigate the impact of the pandemic.In conclusion, the COVID-19 vaccine market in Oman has been developing rapidly, with a high demand for the vaccine and a competitive market. The government has been actively promoting the vaccine and implementing a national vaccination campaign to ensure that all citizens have access to the vaccine. The country's small population and high-income economy have allowed the government to invest in the healthcare sector and control the spread of COVID-19. Despite the impact of the pandemic on the global economy, Oman has implemented measures to support businesses and stimulate the economy.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
